Learn how by using simple motivational interviewing techniques can enable you to support and guide a smoker to stub out the habit About this event We are providing FREE virtual…
Overview of vaping, prevalence of use, toxicology & safety About this event In this presentation, “The New Look of Nicotine Addiction” , participants will receive an overview of vaping 101,…
According to the researchers from CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, in partnership with the University of Pavia and the University of Milan “Statale”, the analysis of the international studies conducted on the humoral response to Covid-19 vaccines confirmed the negative impact of smoking on antibodies levels induced by vaccine and the rapid lowering of the vaccine-elicited IgG titres over six months
The widespread availability of safer nicotine delivery systems without the harms from tobacco, as has been demonstrated for Swedish snus and some other forms of smokeless tobacco products, is a route to ending smoking in the not too distant future as we are already witnessing in Sweden and Norway. A clear distinction needs to be made between the safer snus and refined smokeless tobacco products used in Sweden, Norway and increasingly in the US, and the far riskier unrefined SLT products used in Asia, Middle East and Africa
These are the professors: Margherita Ferrante, Antonio Gagliano, Fabio Galvano, Giuseppe Grasso, Sandro La Vignera, Venerando Rapisarda.
The main goal of the Conference is to introduce the current status of New Alternative Methods and their potential to support Tobacco Harm Reduction worldwide. The aim of the CORESTA conference is also to foster scientific engagement between CORESTA members and THR international community to facilitate the discussion around reduced risk devices and support evidence-based tobacco regulatory policies.
"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"
With the enrollment of the first patient, the project has officially started, thanks to the collaboration of international renew partners: the Addendo Clinic (Catania), the University of Modena and Reggio Emilia, the University of Bologna, and research centres in Warsaw (Poland), Chisinau (Moldova) and Bandung (Indonesia).
CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, has launched a two-year study, the Diasmoke project, to investigate whether vaping or using E-cigarettes reduces the risk of cardiovascular (heart and circulation) disease as compared to normal smoking.
Tobacco harm reduction theories and their fundamental principles are questioned worldwide. New indicators specifically designed to establish the harm reduction potential of low risk tobacco products are examined by CoEHAR, with promising results
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.